Induction of early apoptosis in human nasopharyngeal carcinoma cells by mTHPC-mediated photocytotoxicity

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 2, 2009, Pages 122-127

  Yow, Christine M N ^a   Mak, N K ^b   Leung, Albert W N ^b   Huang, Zheng ^c  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; mTHPC; Nasopharyngeal carcinoma; PDT; Phototoxicity

Indexed keywords

CYTOCHROME C; FLUORESCEIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROTEIN BCL 2; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL ASSAY; CELL COUNT; CELL DAMAGE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRRADIATION; MICROSCOPY; MITOCHONDRIAL MEMBRANE; MORPHOLOGY; NASOPHARYNX CARCINOMA; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; MESOPORPHYRINS; NASOPHARYNGEAL NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 68349119106     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.06.003     Document Type: Article

References (33)

1. Huang Z., Li L., Wang H., et al. Photodynamic therapy-an update on clinical applications. J Innov Opt Health Sci 2 (2009) 73-92
2. Sun Z.Q., and Luo G.Y. Photodynamic therapy for recurrent nasopharyngeal carcinoma after radiotherapy (An analysis of 191 cases). Chin J Laser Med Surg 5 (1996) 134-136 [in Chinese]
3. Tong M.C., van Hasselt C.A., and Woo JK. Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 253 (1996) 189-192
4. Huang Z. Photodynamic therapy in China: 25 years of unique history-Part two: Clinical experience. Photodiag Photodyn Ther 3 (2006) 71-84
5. Li L., Luo R., Liao W., et al. Clinical study of Photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma. Photodiag Photodyn Ther 3 (2006) 266-271
6. Lai J., Tao Z., Xiao J., et al. Effect of photodynamic therapy (PDT) on the expression of pro-apoptotic protein Bak in nasopharyngeal carcinoma (NPC). Lasers Surg Med 29 (2001) 27-32
7. Ali S.M., Chee S.K., Yuen G.Y., and Olivo M. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells. Int J Mol Med 9 (2002) 601-616
8. Koon H., Leung A.W., Yue K.K., and Mak N.K. Photodynamic effect of curcumin on NPC/CNE2 cells. J Environ Pathol Toxicol Oncol 25 (2006) 205-215
9. Wu R.W., Chu E.S., Yow C.M., and Chen J.Y. Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester. Cancer Lett 242 (2006) 112-119
10. Li K.M., Sun X., Koon H.K., et al. Apoptosis and expression of cytokines triggered by pyropheophorbide-a methyl ester-mediated photodynamic therapy in nasopharyngeal carcinoma cells. Photodiag Photodyn Ther 3 (2006) 247-258
11. Xu C.S., and Leung A.W. Photodynamic effects of pyropheophorbide-a methyl ester in nasopharyngeal carcinoma cells. Med Sci Monit 12 (2006) BR257-BR262
12. D'Cruz A.K., Robinson M.H., and Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 26 (2004) 232-240
13. Yow C.M., Chen J.Y., Mak N.K., Cheung N.H., and Leung A.W. Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. Cancer Lett 157 (2000) 123-131
14. Yow C.M., Mak N.K., Szeto S., et al. Photocytotoxic and DNA damaging effect of temoporfin (mTHPC) and merocyanine 540 (MC540) on nasopharyngeal carcinoma cell. Toxicol Lett 115 (2000) 53-61
15. Marchal S., Bezdetnaya L., and Guillemin F. Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29. Biochemistry (Mosc) 69 (2004) 45-49
16. Marchal S., Fadloun A., Maugain E., et al. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem Pharmacol 69 (2005) 1167-1176
17. Gomer C.J. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol 54 (1991) 1093-1107
18. Huang D.P., Ho J.H., Poon Y.F., et al. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 26 (1980) 127-132
19. Kessel D., and Sun H.H. Enhanced responsiveness to photodynamic therapy-induced apoptosis after mitochondrial DNA depletion. Photochem Photobiol 70 (1999) 937-940
20. Xue L.Y., Chiu S.M., and Oleinick N.L. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 20 (2001) 3420-3427
21. Waterhouse N.J., and Trapani J.A. A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death Differ 10 (2003) 853-855
22. Chen J.Y., Mak N.K., Yow C.M., Fung M.C., et al. The binding characteristics and intracellular localization of temoporfin (mTHPC) in myeloid leukemia cells: phototoxicity and mitochondrial damage. Photochem Photobiol 72 (2000) 541-547
23. Green D.R., and Amarante-Mendes G.P. The point of no return: mitochondria, caspases, and the commitment to cell death. Results Probl Cell Differ 24 (1998) 45-61
24. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
25. Granville D.J., Carthy C.M., Jiang H., et al. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett 437 (1998) 5-10
26. Vantieghem A., Xu Y., Declercq W., et al. Different pathways mediate cytochrome c release after photodynamic therapy with hypericin. Photochem Photobiol 74 (2001) 133-142
27. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiag Photodyn Ther 2 (2005) 1-23
28. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
29. Teiten M.H., Bezdetnaya L., Morlière P., Santus R., and Guillemin F. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br J Cancer 88 (2003) 146-152
30. Teiten M.H., Marchal S., D'Hallewin M.A., Guillemin F., and Bezdetnaya L. Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells. Photochem Photobiol 78 (2003) 9-14
31. Triesscheijn M., Ruevekamp M., Aalders M., Baas P., and Stewart F.A. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Photochem Photobiol 81 (2005) 1161-1167
32. Kessel D., and Castelli M. Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem Photobiol 74 (2001) 318-322
33. Marchal S., François A., Dumas D., Guillemin F., and Bezdetnaya L. Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells. Br J Cancer 96 (2007) 944-951